תוצאות חיפוש - Labianca, Roberto

Refine Results
  1. 1
    Optimizing use of opiates in the management of cancer pain

    Optimizing use of opiates in the management of cancer pain מאת Mandalà, Mario, Moro, Cecilia, Labianca, Roberto, Cremonesi, Marco, Barni, Sandro

    יצא לאור 2006
    קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  2. 2
    Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

    Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer מאת Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe

    יצא לאור 2008
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  3. 3
    Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

    Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer מאת Labianca, Alice, Bosetti, Tommaso, Indini, Alice, Negrini, Giorgia, Labianca, Roberto Francesco

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  4. 4
    Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients

    Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients מאת Apolone, Giovanni, Bertetto, Oscar, Caraceni, Augusto, Corli, Oscar, De Conno, Franco, Labianca, Roberto, Maltoni, Marco, Nicora, Mariaflavia, Torri, Valter, Zucco, Furio

    יצא לאור 2006
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  5. 5
    Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

    Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study מאת Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  6. 6
    Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

    Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial מאת Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero

    יצא לאור 2003
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  7. 7
    Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma

    Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma מאת Mandalà, Mario, Imberti, Gian Lorenzo, Piazzalunga, Dario, Belfiglio, Maurizio, Lucisano, Giuseppe, Labianca, Roberto, Marchesi, Lorenzo, Merelli, Barbara, Robone, Silvana, Poletti, Paola, Milesi, Laura, Tondini, Carlo

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  8. 8
    Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set

    Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set מאת Hubbard, Joleen, Thomas, David M., Yothers, Greg, Green, Erin, Blanke, Charles, O'Connell, Michael J., Labianca, Roberto, Shi, Qian, Bleyer, Archie, de Gramont, Aimery, Sargent, Daniel

    יצא לאור 2012
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  9. 9
    DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

    DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy מאת Sinicrope, Frank A., Foster, Nathan R., Thibodeau, Stephen N., Marsoni, Silvia, Monges, Genevieve, Labianca, Roberto, Yothers, Greg, Allegra, Carmen, Moore, Malcolm J., Gallinger, Steven, Sargent, Daniel J.

    יצא לאור 2011
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  10. 10
    Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy

    Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy מאת Sinicrope, Frank A., Foster, Nathan R., Yothers, Greg, Benson, Al, Seitz, Jean Francois, Labianca, Roberto, Goldberg, Richard M., DeGramont, Aimery, O’Connell, Michael J., Sargent, Daniel J.

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  11. 11
    The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cancer: Current Status

    The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance... מאת Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel

    יצא לאור 2014
    קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  12. 12
    The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

    The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi... מאת André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.

    יצא לאור 2013
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  13. 13
    ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

    ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer מאת Renfro, Lindsay A., Grothey, Axel, Xue, Yuan, Saltz, Leonard B., André, Thierry, Twelves, Chris, Labianca, Roberto, Allegra, Carmen J., Alberts, Steven R., Loprinzi, Charles L., Yothers, Greg, Sargent, Daniel J.

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  14. 14
    Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

    Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit... מאת Scartozzi, Mario, Bearzi, Italo, Mandolesi, Alessandra, Pierantoni, Chiara, Loupakis, Fotios, Zaniboni, Alberto, Negri, Francesca, Quadri, Antonello, Zorzi, Fausto, Galizia, Eva, Berardi, Rossana, Biscotti, Tommasina, Labianca, Roberto, Masi, Gianluca, Falcone, Alfredo, Cascinu, Stefano

    יצא לאור 2009
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  15. 15
    Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials מאת Sargent, Daniel, Sobrero, Alberto, Grothey, Axel, O'Connell, Michael J., Buyse, Marc, Andre, Thierry, Zheng, Yan, Green, Erin, Labianca, Roberto, O'Callaghan, Chris, Seitz, Jean Francois, Francini, Guido, Haller, Daniel, Yothers, Greg, Goldberg, Richard, de Gramont, Aimery

    יצא לאור 2009
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  16. 16
    Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database

    Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database מאת Papamichael, Demetris, Renfro, Lindsay A., Matthaiou, Christiana, Yothers, Greg, Saltz, Leonard, Guthrie, Katherine, Van Cutsem, Eric, Schmoll, Hans-Joachim, Labianca, Roberto, André, Thierry, O’Connell, Michael, Alberts, Steven R., Haller, Daniel G., Kountourakis, Panteleimon, Sargent, Daniel J.

    יצא לאור 2016
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  17. 17
    First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial

    First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the S... מאת Giampieri, Riccardo, Puzzoni, Marco, Daniele, Bruno, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Pella, Nicoletta, Zampino, Maria Giulia, Sozzi, Pietro, Germano, Domenico, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  18. 18
    Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

    Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer מאת Sargent, Daniel J., Marsoni, Silvia, Monges, Genevieve, Thibodeau, Stephen N., Labianca, Roberto, Hamilton, Stanley R., French, Amy J., Kabat, Brian, Foster, Nathan R., Torri, Valter, Ribic, Christine, Grothey, Axel, Moore, Malcolm, Zaniboni, Alberto, Seitz, Jean-Francois, Sinicrope, Frank, Gallinger, Steven

    יצא לאור 2010
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  19. 19
    Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phas... מאת André, Thierry, Meyerhardt, Jeffrey, Iveson, Timothy, Sobrero, Alberto, Yoshino, Takayuki, Souglakos, Ioannis, Grothey, Axel, Niedzwiecki, Donna, Saunders, Mark, Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Vernerey, Dewi, Meyers, Jeffrey, Harkin, Andrea, Torri, Valter, Oki, Eiji, Georgoulias, Vassilis, Taieb, Julien, Shields, Anthony, Shi, Qian

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:
  20. 20
    Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

    Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database מאת Cheung, Winson Y., Renfro, Lindsay A., Kerr, David, de Gramont, Aimery, Saltz, Leonard B., Grothey, Axel, Alberts, Steven R., Andre, Thierry, Guthrie, Katherine A., Labianca, Roberto, Francini, Guido, Seitz, Jean-Francois, O’Callaghan, Chris, Twelves, Chris, Van Cutsem, Eric, Haller, Daniel G., Yothers, Greg, Sargent, Daniel J.

    יצא לאור 2016
    קבל טקסט מלא קבל טקסט מלא קבל טקסט מלא
    Text
    הוספה למועדפים
    שמור ב:

כלי חיפוש: